Welcome to LookChem.com Sign In|Join Free
  • or
N-(2-Methoxyethyl)-N'-[N-(3,5-Difluorophenylacetyl)-L-Alaninyl]-(S)-2-Aminohexanamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

208254-45-9

Post Buying Request

208254-45-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

208254-45-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 208254-45-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,8,2,5 and 4 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 208254-45:
(8*2)+(7*0)+(6*8)+(5*2)+(4*5)+(3*4)+(2*4)+(1*5)=119
119 % 10 = 9
So 208254-45-9 is a valid CAS Registry Number.

208254-45-9Downstream Products

208254-45-9Relevant academic research and scientific papers

Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis

-

, (2008/06/13)

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

-

, (2008/06/13)

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis.

Compounds for inhibiting β-amyloid peptide release and/or its synthesis

-

, (2008/06/13)

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 208254-45-9